Form 4: Green Thumb Industries CFO Mathew Faulkner Reports Stock Option Grant and Tax Withholding
SEC Form 4 Filing
CFO Mathew Faulkner reports acquisition of stock options and shares, as well as a disposition of shares for tax withholding.
Summary
- On April 1, 2024, Mathew Faulkner, CFO of Green Thumb Industries Inc., reported transactions involving the company's securities.
- Faulkner acquired 26,069 Subordinate Voting Shares at $0 and 32,869 Employee Stock Options with an exercise price of $14.96.
- He also disposed of 5,405 Subordinate Voting Shares at $14.52 for tax withholding purposes.
- Following these transactions, Faulkner directly owns 1,814 Multiple Voting Shares and 131,472 Subordinate Voting Shares.
- He also directly owns 32,869 derivative securities in the form of Employee Stock Options.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine filing indicating standard compensation practices. The acquisition of shares and options is mildly positive, while the sale for tax purposes is neutral.
Positives
- The acquisition of stock options by the CFO could be seen as a positive sign, indicating confidence in the company's future performance.
Negatives
- The disposal of shares for tax withholding, while routine, slightly reduces the CFO's direct ownership in the company.
Risks
- The value of the stock options is dependent on the future performance of Green Thumb Industries' stock price.
- Changes in market conditions or company performance could impact the value of these holdings.
Future Outlook
The document does not contain specific forward-looking statements, but the vesting schedule of the stock options suggests a multi-year commitment from the CFO.
Industry Context
This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies within the cannabis industry.
Comparison to Industry Standards
- Stock option grants are a common form of compensation for executives in the cannabis industry, similar to practices at companies like Curaleaf, Trulieve, and Canopy Growth.
- The vesting schedule of the options is typical, aligning with industry standards for incentivizing long-term performance.
Stakeholder Impact
- The filing provides transparency to shareholders regarding executive compensation and ownership.
- The stock option grant aligns management's interests with those of shareholders.
Key Dates
| Date | Description |
|---|---|
| 04/01/2024 | Date of earliest transaction: Acquisition of Subordinate Voting Shares and Employee Stock Options, and disposition of shares for tax withholding. |
| 03/01/2025 | First vesting date for one-third of the stock options. |
| 03/01/2026 | Second vesting date for one-third of the stock options. |
| 03/01/2027 | Third vesting date for one-third of the stock options. |
| 04/01/2031 | Expiration date of the stock options. |
| 04/03/2024 | Date of signature for the SEC Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.